Sana Biotechnology, Inc.
SEC CIK 1770121 · SANA · last insider filing 2026-06-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Nelsen Robert | Director | filed 2021 - 2026 |
| Yang Patrick Y | Director | filed 2021 - 2026 |
| Mulligan Richard | Director · Head of SanaX | filed 2021 - 2026 |
| Bishop Hans Edgar | Director | filed 2021 - 2026 |
| Bilenker Joshua H. | Director | filed 2021 - 2026 |
| Rosiello Robert L. | Director | filed 2025 - 2026 |
| Reicin Alise | Director | filed 2021 - 2026 |
| Seitz Michelle | Director | filed 2021 - 2026 |
| Harr Steve | Director · President & CEO | filed 2021 - 2026 |
| Wilderotter Mary Agnes | Director | filed 2021 - 2025 |
| Cole Douglas G. | Director | filed 2021 - 2024 |
| von Maltzahn Geoffrey | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Patel Dhavalkumar Dhirajlal | EVP, Chief Scientific Officer | filed 2026 - 2026 |
| Wyrick Susan D. | See Remarks | filed 2024 - 2026 |
| Piper Brian | EVP, Chief Financial Officer | filed 2026 - 2026 |
| Cassidy Bernard J | EVP & General Counsel | filed 2022 - 2025 |
| Williams Douglas E | EVP & President, R&D | filed 2023 - 2024 |
| Hardy Nathan | SVP, Chief Financial Officer | filed 2021 - 2024 |
| Hordo Christian | SVP, Chief Business Officer | filed 2021 - 2024 |
| Macdonald James J. | See Remarks | filed 2021 - 2022 |
| Agarwal Sunil | See Remarks | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.